P. Tacrolimus-et-le-vitiligo and .. , .68 I.Le tacrolimus par voie topique, p.68

B. Dréno, Anatomie et physiologie de la peau et de ses annexes, Annales de Dermatologie et de V??n??r??ologie, vol.136, issue.0, pp.247-51, 2007.
DOI : 10.1016/S0151-9638(09)72527-X

T. Passeron, R. Ballotti, J. Ortonne, and . Mélanogenèse, EMC -Dermatol-Cosmétologie, nov, vol.2, issue.4, pp.204-220, 2005.

B. Khaitan, S. Kathuria, and M. Ramam, A descriptive study to characterize segmental vitiligo, Indian Journal of Dermatology, Venereology, and Leprology, vol.78, issue.6
DOI : 10.4103/0378-6323.102362

J. Nordlund, The epidemiology and genetics of vitiligo, Clinics in Dermatology, vol.15, issue.6, pp.875-883, 1997.
DOI : 10.1016/S0738-081X(97)00128-4

V. Sehgal and G. Srivastava, Vitiligo: Compendium of clinico-epidemiological features, Indian Journal of Dermatology, Venereology and Leprology, vol.73, issue.3
DOI : 10.4103/0378-6323.32708

X. Zhang, J. Liu, G. J. Li, M. Xiong, Q. Wu et al., Characteristics of genetic epidemiology and genetic models for vitiligo, Journal of the American Academy of Dermatology, vol.51, issue.3, pp.383-90, 2004.
DOI : 10.1016/j.jaad.2003.12.044

S. Nath, J. Kelly, B. Namjou, T. Lam, G. Bruner et al., Evidence for a Susceptibility Gene, SLEV1, on Chromosome 17p13 in Families with Vitiligo-Related Systemic Lupus Erythematosus, The American Journal of Human Genetics, vol.69, issue.6, pp.1401-1407, 2001.
DOI : 10.1086/324470

A. Alkhateeb, G. Stetler, W. Old, J. Talbert, C. Uhlhorn et al., Mapping of an autoimmunity susceptibility locus (AIS1) to chromosome 1p31.3-p32.2, Human Molecular Genetics, vol.11, issue.6, pp.661-668, 2002.
DOI : 10.1093/hmg/11.6.661

R. Spritz, K. Gowan, D. Bennett, and P. Fain, Novel Vitiligo Susceptibility Loci on Chromosomes 7 (AIS2) and 8 (AIS3), Confirmation of SLEV1 on Chromosome 17, and Their Roles in an Autoimmune Diathesis, The American Journal of Human Genetics, vol.74, issue.1, pp.188-91, 2004.
DOI : 10.1086/381134

A. Al-fouzan, M. Arbash, F. Fouad, S. Kaaba, M. Mousa et al., STUDY OF HLA CLASS I/II AND T LYMPHOCYTE SUBSETS IN KUWAITI VITILIGO PATIENTS, European Journal of Immunogenetics, vol.19, issue.2, pp.209-222, 1995.
DOI : 10.1111/j.1365-2133.1976.tb00822.x

I. Ando, H. Chi, H. Nakagawa, and F. Otsuka, Difference in clinical features and HLA antigens between familial and non-familial vitiligo of non-segmental type, British Journal of Dermatology, vol.89, issue.4, pp.408-418, 1993.
DOI : 10.1002/gepi.1370020107

M. Buc, B. Busová, E. Hegyi, and K. Kolibásová, Vitiligo is associated with HLA-A2 and HLA-Dw7 in the Slovak populations, Folia Biol, vol.42, issue.12, pp.23-28, 1996.

Y. Jin, C. Mailloux, K. Gowan, S. Riccardi, G. Laberge et al., in Vitiligo-Associated Multiple Autoimmune Disease, New England Journal of Medicine, vol.356, issue.12, pp.1216-1241, 2007.
DOI : 10.1056/NEJMoa061592

N. Rezaei, N. Gavalas, A. Weetman, and E. Kemp, Autoimmunity as an aetiological factor in vitiligo, Journal of the European Academy of Dermatology and Venereology, vol.124, issue.Suppl, pp.865-76, 2007.
DOI : 10.1111/j.1468-3083.2007.02228.x

K. Ongenae, N. Van-geel, and J. Naeyaert, Evidence for an Autoimmune Pathogenesis of Vitiligo, Pigment Cell Research, vol.128, issue.2, pp.90-100, 2003.
DOI : 10.1111/j.1365-2133.2000.03712.x

M. Picardo and A. Taieb, Oxidative Stress, pp.231-238
DOI : 10.1007/978-3-540-69361-1_27

A. Alikhan, L. Felsten, M. Daly, and V. Petronic-rosic, Vitiligo: A comprehensive overview, Journal of the American Academy of Dermatology, vol.65, issue.3, pp.473-91, 2011.
DOI : 10.1016/j.jaad.2010.11.061

M. Picardo and A. Taieb, The Neurogenic Hypothesis in Segmental Vitiligo, pp.302-307

M. Cucchi, P. Frattini, G. Santagostino, and G. Orecchia, Higher Plasma Catecholamine and Metabolite Levels in the Early Phase of Nonsegmental Vitiligo, Pigment Cell Research, vol.13, issue.1, pp.28-32, 2000.
DOI : 10.1034/j.1600-0749.2000.130106.x

Z. Shahin, T. Leheta, A. Hay, R. , A. Aal et al., Detection of plasma and urinary monoamines and their metabolites in nonsegmental vitiligo, Acta Dermatovenerol Croat ADC, vol.20, issue.1, pp.14-20, 2012.

S. Hasse, N. Gibbons, H. Rokos, L. Marles, and K. Schallreuter, Perturbed 6-Tetrahydrobiopterin Recycling via Decreased Dihydropteridine Reductase in Vitiligo: More Evidence for H2O2 Stress, Journal of Investigative Dermatology, vol.122, issue.2, pp.307-320, 2004.
DOI : 10.1046/j.0022-202X.2004.22230.x

K. Schallreuter, Successful Treatment of Oxidative Stress in Vitiligo, Skin Pharmacology and Physiology, vol.12, issue.3, pp.132-140, 1999.
DOI : 10.1159/000029867

M. Eskandani, J. Golchai, N. Pirooznia, and S. Hasannia, Oxidative stress level and tyrosinase activity in vitiligo patients, Indian J Dermatol, vol.55, issue.1, pp.15-24, 2010.

M. Dell-'anna, V. Maresca, S. Briganti, E. Camera, M. Falchi et al., Mitochondrial Impairment in Peripheral Blood Mononuclear Cells During the Active Phase of Vitiligo, Journal of Investigative Dermatology, vol.117, issue.4, pp.908-921, 2001.
DOI : 10.1046/j.0022-202x.2001.01459.x

S. Glassman, Vitiligo, reactive oxygen species and T-cells, Clinical Science, vol.174, issue.3, pp.99-120, 1979.
DOI : 10.1182/blood-2006-07-034066

D. Kuner, W. Hartschuh, B. Khan-durani, and . Heinrich-köbner-und-der-«-isomorphe-reizeffekt, Heinrich K??bner und der "isomorphe Reizeffekt", Der Hautarzt, vol.54, issue.3, pp.274-282, 2003.
DOI : 10.1007/s00105-002-0470-5

G. Weiss, A. Shemer, and H. Trau, The Koebner phenomenon: review of the literature, Journal of the European Academy of Dermatology and Venereology, vol.19, issue.3, pp.241-249, 2002.
DOI : 10.1046/j.1473-2165.2002.00406.x

N. Van-geel, R. Speeckaert, D. Wolf, J. Bracke, S. Chevolet et al., Clinical significance of Koebner???s phenomenon in vitiligo, British Journal of Dermatology, vol.167, issue.5, pp.1017-1041, 2012.
DOI : 10.1111/j.1365-2133.2012.11111.x

A. Kanwar, R. Mahajan, and D. Parsad, Koebner phenomenon in vitiligo in an Indian population, Clinical and Experimental Dermatology, vol.165, issue.5, pp.554-559, 2013.
DOI : 10.1111/j.1365-2230.2012.04422.x

K. Ezzedine, V. Eleftheriadou, M. Whitton, N. Van-geel, and . Vitiligo, Vitiligo, The Lancet, vol.386, issue.9988, pp.74-84, 2015.
DOI : 10.1016/S0140-6736(14)60763-7

K. Ezzedine, H. Lim, T. Suzuki, I. Katayama, I. Hamzavi et al., Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference, Pigment Cell & Melanoma Research, vol.7, issue.Suppl, pp.1-13, 2012.
DOI : 10.1111/j.1755-148X.2012.00997.x

S. Hann and H. Lee, Segmental vitiligo: Clinical findings in 208 patients, Journal of the American Academy of Dermatology, vol.35, issue.5, pp.671-675, 1996.
DOI : 10.1016/S0190-9622(96)90718-5

S. Hann, Y. Park, and W. Chun, Clinical features of vitiligo, Clinics in Dermatology, vol.15, issue.6, pp.891-898, 1997.
DOI : 10.1016/S0738-081X(97)00130-2

D. Kim, S. Oh, and S. Hann, Classification of segmental vitiligo on the face: clues for prognosis, British Journal of Dermatology, vol.57, issue.Suppl. 2, pp.1004-1013, 2011.
DOI : 10.1111/j.1365-2133.2010.10202.x

R. Yaghoobi, M. Omidian, and N. Bagherani, Vitiligo: A review of the published work, The Journal of Dermatology, vol.171, issue.6S, pp.419-450, 2011.
DOI : 10.1111/j.1346-8138.2010.01139.x

K. Ezzedine, L. Thuaut, A. Jouary, T. Ballanger, F. Taieb et al., Latent class analysis of a series of 717 patients with vitiligo allows the identification of two clinical subtypes, Pigment Cell & Melanoma Research, vol.20, issue.1, pp.134-143, 2014.
DOI : 10.1111/pcmr.12186

K. Alghamdi, A. Kumar, A. Taïeb, and K. Ezzedine, Assessment methods for the evaluation of vitiligo, Journal of the European Academy of Dermatology and Venereology, vol.14, issue.12, pp.1463-71, 2012.
DOI : 10.1111/j.1468-3083.2012.04505.x

D. Gawkrodger, A. Ormerod, L. Shaw, I. Mauri-sole, M. Whitton et al., Guideline for the diagnosis and management of vitiligo, British Journal of Dermatology, vol.5, issue.5, pp.1051-76, 2008.
DOI : 10.1111/j.1365-2133.2008.08881.x

M. Picardo and A. Taieb, Topical corticosteroids, pp.327-357

Y. Zhang, J. Mooneyan-ramchurn, N. Zuo, Y. Feng, and X. S. , Vitiligo nonsurgical treatment: a review of latest treatment researches, Dermatologic Therapy, vol.168, issue.5, pp.298-303, 2014.
DOI : 10.1111/dth.12143

M. Picardo and A. Taieb, Vitamine D analogues, pp.339-381

M. Picardo and A. Taieb, PUVA and related treatments, pp.345-51

A. Pacifico and G. Leone, Photo(chemo)therapy for vitiligo, Photodermatology, Photoimmunology & Photomedicine, vol.15, issue.(Suppl 1), pp.261-77, 2011.
DOI : 10.1111/j.1600-0781.2011.00606.x

M. Njoo, W. Westerhof, J. Bos, and P. Bossuyt, The development of guidelines for the treatment of vitiligo Clinical Epidemiology Unit of the Istituto Dermopatico dell'Immacolata-Istituto di Recovero e Cura a Carattere Scientifico (IDI-IRCCS) and the Archives of Dermatology, Arch Dermatol. déc, vol.135, issue.12, pp.1514-1535, 1999.

M. Picardo and A. Taieb, UVB total Body and Targeted phototherapies, pp.353-65

A. Alhowaish, N. Dietrich, M. Onder, and K. Fritz, Effectiveness of a 308-nm excimer laser in treatment of vitiligo: a review, Lasers in Medical Science, vol.24, issue.6, pp.1035-1076, 2013.
DOI : 10.1007/s10103-012-1185-1

M. Picardo and A. Taieb, Surgical therapies, pp.393-415

J. Nordlund, Surgical management of vitiligo, Journal of the American Academy of Dermatology, vol.57, issue.6, pp.1105-1111, 2007.
DOI : 10.1016/j.jaad.2007.06.019

L. Felsten, A. Alikhan, and V. Petronic-rosic, Vitiligo: A comprehensive overview, Journal of the American Academy of Dermatology, vol.65, issue.3, pp.493-514, 2011.
DOI : 10.1016/j.jaad.2010.10.043

M. Njoo and W. W. Vitiligo, Vitiligo, American Journal of Clinical Dermatology, vol.135, issue.3, pp.167-81, 2001.
DOI : 10.2165/00128071-200102030-00006

D. Gupta, Microskin grafting for Vitiligo
DOI : 10.1007/978-1-84882-605-2

D. Gupta, Thin and Ultra Thin Split Thickness Skin Grafts (STSG-UT, STSG-T)
DOI : 10.1007/978-1-84882-605-2_5

D. Gupta, Split Thickness Skin Sheet Grafting, Microskin grafting for Vitiligo

M. Picardo and A. Taieb, Vitamins and Antioxydants : topical and systemic, pp.369-74

M. Tjioe, M. Gerritsen, L. Juhlin, and P. Van-de-kerkhof, Treatment of Vitiligo Vulgaris with Narrow Band UVB (311nm) for One Year and the Effect of Addition of Folic Acid and Vitamin B12, Acta Dermato-Venereologica, vol.82, issue.5, pp.369-72, 2002.
DOI : 10.1080/000155502320624113

R. Roelandts, J. Vanhee, A. Bonamie, L. Kerkhofs, and H. Degreef, A Survey of Ultraviolet Absorbers in Commercially Available Sun Products, International Journal of Dermatology, vol.73, issue.4, pp.247-55, 1983.
DOI : 10.1111/j.1600-0536.1980.tb05600.x

M. Picardo and A. Taieb, Combined Therapies for Vitiligo, pp.417-438

M. Picardo and A. Taieb, Depigmenting Agents, pp.439-481
DOI : 10.1007/978-3-540-69361-1_52

S. Dahan, H. Cartier, and G. Toubel, Les lasers en dermatologie, Ann Dermatol Vénéréologie, vol.138, issue.11, p.807, 2011.

A. Gupta, A. Adamiak, and M. Chow, Tacrolimus: a review of its use for the management of dermatoses, Journal of the European Academy of Dermatology and Venereology, vol.92, issue.2, pp.100-114, 2002.
DOI : 10.1016/S0041-1345(98)01917-4

N. Silverberg, P. Lin, L. Travis, J. Farley-li, A. Mancini et al., Tacrolimus ointment promotes repigmentation of vitiligo in children: A review of 57 cases, Journal of the American Academy of Dermatology, vol.51, issue.5, pp.760-766, 2004.
DOI : 10.1016/j.jaad.2004.05.036

C. Lan, G. Chen, M. Chiou, C. Wu, C. Chang et al., FK506 promotes melanocyte and melanoblast growth and creates a favourable milieu for cell migration via keratinocytes: possible mechanisms of how tacrolimus ointment induces repigmentation in patients with vitiligo, British Journal of Dermatology, vol.30, issue.Suppl., pp.498-505, 2005.
DOI : 10.1111/j.1365-2133.2005.06739.x

M. Picardo and A. Taieb, Calcineurin inhibitors, pp.331-339

H. Kang and Y. Choi, FK506 increases pigmentation and migration of human melanocytes, British Journal of Dermatology, vol.155, issue.5, pp.1037-1077, 2006.
DOI : 10.1111/j.1365-2133.2004.06280.x

A. Kanwar, S. Dogra, and D. Parsad, Topical tacrolimus for treatment of childhood vitiligo in Asians, Clinical and Experimental Dermatology, vol.139, issue.6, pp.589-92, 2004.
DOI : 10.1046/j.1523-1747.1998.00323.x

D. De and A. Kanwar, Tacrolimus-Induced Hyperpigmentation in a Patch of Vitiligo, SKINmed, vol.74, issue.2, pp.93-97, 2008.
DOI : 10.1111/j.1365-2133.2005.06739.x

S. Radakovic, J. Breier-maly, R. Konschitzky, H. Kittler, P. Sator et al., Response of vitiligo to once- vs. twice-daily topical tacrolimus: a controlled prospective, randomized, observer-blinded trial, Journal of the European Academy of Dermatology and Venereology, vol.153, issue.Suppl., pp.951-954, 2009.
DOI : 10.1111/j.1468-3083.2009.03138.x

A. Hartmann, E. Bröcker, and H. Hamm, Repigmentation of pretibial vitiligo with calcineurin inhibitors under occlusion, JDDG, vol.3, issue.5, pp.383-388, 2008.
DOI : 10.1016/j.jaad.2005.06.013

E. Tanghetti, Tacrolimus ointment 0.1% produces repigmentation in patients with vitiligo: results of a prospective patient series, Cutis. févr, vol.71, issue.2, pp.158-62, 2003.

A. Hartmann, E. Bröcker, and H. Hamm, Occlusive Treatment Enhances Efficacy of Tacrolimus 0.1% Ointment in Adult Patients with Vitiligo: Results of a Placebo-controlled 12-month Prospective Study, Acta Dermato Venereologica, vol.88, issue.5, pp.474-483, 2008.
DOI : 10.2340/00015555-0464

M. Cavalié, K. Ezzedine, E. Fontas, H. Montaudié, E. Castela et al., Maintenance Therapy of Adult Vitiligo with 0.1% Tacrolimus Ointment: A Randomized, Double Blind, Placebo???Controlled Study, Journal of Investigative Dermatology, vol.135, issue.4, pp.970-974, 2015.
DOI : 10.1038/jid.2014.527

A. Kawalek, J. Spencer, and R. Phelps, Combined Excimer Laser and Topical Tacrolimus for the Treatment of Vitiligo, Dermatologic Surgery, vol.30, issue.2, pp.130-135, 2004.
DOI : 10.1097/00042728-200402000-00002

T. Passeron, N. Ostovari, W. Zakaria, E. Fontas, J. Larrouy et al., Topical Tacrolimus and the 308-nm Excimer Laser, Archives of Dermatology, vol.140, issue.9, pp.1065-1074, 2004.
DOI : 10.1001/archderm.140.9.1065

J. Castanedo-cazares, V. Lepe, and B. Moncada, Repigmentation of chronic vitiligo lesions by following tacrolimus plus ultraviolet-B-narrow-band, Photodermatology, Photoimmunology and Photomedicine, vol.102, issue.1, pp.35-41, 2003.
DOI : 10.1046/j.1365-2133.2001.04286.x

T. Lotti, G. Buggiani, M. Troiano, G. Assad, J. Delescluse et al., Targeted and combination treatments for vitiligo???Comparative evaluation of different current modalities in 458 subjects, Dermatologic Therapy, vol.142, issue.1, pp.20-26, 2008.
DOI : 10.1111/j.1529-8019.2008.00198.x

K. Sardana, P. Bhushan, K. Garg, and V. , Effect of Tacrolimus on Vitiligo in Absence of UV Radiation Exposure, Archives of Dermatology, vol.143, issue.1, p.119, 2007.
DOI : 10.1001/archderm.143.1.119

C. Baldo, . Prizio, and M. Porzio, Topical tacrolimus and vitiligo: Our experience in sixty cases, G Ital Dermatol Venereol, vol.142, issue.6, pp.621-626, 2007.

P. Almeida, L. Borrego, J. Rodríguez-lópez, D. Luján, D. Cameselle et al., [Vitiligo. Treatment of 12 cases with topical tacrolimus]. Actas Dermo-Sifiliográficas, avr, vol.96, issue.3, pp.159-63, 2005.

P. Grimes, R. Morris, E. Avaniss-aghajani, T. Soriano, M. Meraz et al., Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines, Journal of the American Academy of Dermatology, vol.51, issue.1, pp.52-61, 2004.
DOI : 10.1016/j.jaad.2003.12.031

V. Lepe, B. Moncada, J. Castanedo-cazares, M. Torres-alvarez, C. Ortiz et al., A Double-blind Randomized Trial of 0.1% Tacrolimus vs 0.05% Clobetasol for the Treatment of Childhood Vitiligo, Archives of Dermatology, vol.139, issue.5, pp.581-586, 2003.
DOI : 10.1001/archderm.139.5.581

L. Travis, J. Weinberg, and N. Silverberg, Successful Treatment of Vitiligo With 0.1% Tacrolimus Ointment, Archives of Dermatology, vol.139, issue.5, pp.571-575, 2003.
DOI : 10.1001/archderm.139.5.571

P. Grimes, T. Soriano, and M. Dytoc, Topical tacrolimus for repigmentation of vitiligo, Journal of the American Academy of Dermatology, vol.47, issue.5, pp.789-91, 2002.
DOI : 10.1067/mjd.2002.126250

D. Smith, S. Tofte, and J. Hanifin, Repigmentation of Vitiligo with Topical Tacrolimus, Dermatology, vol.205, issue.3
DOI : 10.1159/000065845

N. Ho, E. Pope, M. Weinstein, S. Greenberg, C. Webster et al., A double-blind, randomized, placebo-controlled trial of topical tacrolimus 0??1% vs. clobetasol propionate 0??05% in childhood vitiligo, British Journal of Dermatology, vol.27, issue.3, pp.626-658, 2011.
DOI : 10.1111/j.1365-2133.2011.10351.x

D. Fai, N. Cassano, and G. Vena, Narrow-band UVB phototherapy combined with tacrolimus ointment in vitiligo: a review of 110 patients, Journal of the European Academy of Dermatology and Venereology, vol.153, issue.7, pp.916-936, 2007.
DOI : 10.1111/j.1468-3083.2006.02101.x

D. Mehrabi and A. Pandya, A Randomized, Placebo-Controlled, Double-blind Trial Comparing Narrowband UV-B Plus 0.1% Tacrolimus Ointment With Narrowband UV-B Plus Placebo in the Treatment of Generalized Vitiligo, Archives of Dermatology, vol.142, issue.7, pp.927-936, 2006.
DOI : 10.1001/archderm.142.7.927

N. Ostovari, T. Passeron, J. Lacour, and J. Ortonne, Lack of Efficacy of Tacrolimus in the Treatment of Vitiligo in the Absence of UV-B Exposure, Archives of Dermatology, vol.142, issue.2, pp.252-255, 2006.
DOI : 10.1001/archderm.142.2.252

Y. Jang, S. Jung, J. Shin, and H. Kang, Triple Combination of Systemic Corticosteroids, Excimer Laser, and Topical Tacrolimus in the Treatment of Recently Developed Localized Vitiligo, Annals of Dermatology, vol.27, issue.1, pp.104-111, 2015.
DOI : 10.5021/ad.2015.27.1.104

J. Bae, H. Yoo, H. Kim, J. Lee, and G. Kim, Combination therapy with 308-nm excimer laser, topical tacrolimus, and short-term systemic corticosteroids for segmental vitiligo: A retrospective study of 159 patients, Journal of the American Academy of Dermatology, vol.73, issue.1, pp.76-82, 2015.
DOI : 10.1016/j.jaad.2015.04.008